{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:09Z","timestamp":1792801629571,"version":"4.5.0"},"reference-count":241,"publisher":"Elsevier","isbn-type":[{"value":"9780443219337","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z1A-DA000611"],"award-info":[{"award-number":["Z1A-DA000611"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.apha.2023.10.006","type":"book-chapter","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T04:50:46Z","timestamp":1700628646000},"page":"287-326","source":"Crossref","is-referenced-by-count":15,"title":["Modafinil, an atypical CNS stimulant?"],"prefix":"10.1016","member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/bs.apha.2023.10.006_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-8993(00)02298-8","article-title":"D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex","volume":"867","author":"Abekawa","year":"2000","journal-title":"Brain Research"},{"issue":"8","key":"10.1016\/bs.apha.2023.10.006_bib2","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1021\/acschemneuro.7b00094","article-title":"The isomeric preference of an atypical dopamine transporter inhibitor contributes to its selection of the transporter conformation","volume":"8","author":"Abramyan","year":"2017","journal-title":"ACS Chemical Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10805-018-9320-7","article-title":"The white version of cheating? Ethical and social equity concerns of cognitive enhancing drug users in higher education","volume":"17","author":"Aikins","year":"2019","journal-title":"Journal of Academic Ethics"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.30773\/pi.2016.10.25","article-title":"Modafinil dependence: A case with attention-deficit\/hyperactivity disorder","volume":"15","author":"Alacam","year":"2018","journal-title":"Psychiatry Investigation"},{"key":"10.1016\/bs.apha.2023.10.006_bib5","doi-asserted-by":"crossref","unstructured":"American-Psychiatric-Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). American Psychiatric Association Publishing, Arlington, VA.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-010-1839-2","article-title":"Dopamine transporter-related effects of modafinil in rhesus monkeys","volume":"210","author":"Andersen","year":"2010","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2023.10.006_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.apha.2023.10.006_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpsychires.2014.09.013","article-title":"Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: Systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Andrade","year":"2015","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-016-0056-7","article-title":"Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: A comprehensive review","volume":"11","author":"Angarita","year":"2016","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1087054712441969","article-title":"A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD","volume":"18","author":"Arnold","year":"2014","journal-title":"Journal of Attention Disorders"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A systematic review of modafinil: Potential clinical uses and mechanisms of action","volume":"67","author":"Ballon","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hup.596","article-title":"Effects of modafinil on cognitive and meta-cognitive performance","volume":"19","author":"Baranski","year":"2004","journal-title":"Human Psychopharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib13","first-page":"493","article-title":"Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance","volume":"70","author":"Batejat","year":"1999","journal-title":"Aviation, Space, and Environmental Medicine"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib14","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.euroneuro.2015.07.028","article-title":"Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review","volume":"25","author":"Battleday","year":"2015","journal-title":"European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacological Reviews"},{"issue":"20","key":"10.1016\/bs.apha.2023.10.006_bib16","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.0b013e3181c2937c","article-title":"The locus ceruleus norepinephrine system: Functional organization and potential clinical significance","volume":"73","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pneurobio.2011.06.002","article-title":"Cholinergic modulation of cognition: Insights from human pharmacological functional neuroimaging","volume":"94","author":"Bentley","year":"2011","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/bs.apha.2023.10.006_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annual Review of Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.116.236000","article-title":"Modafinil activates phasic dopamine signaling in dorsal and ventral striata","volume":"359","author":"Bobak","year":"2016","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pbb.2011.04.017","article-title":"Cognitive enhancers in the treatment of substance use disorders: Clinical evidence","volume":"99","author":"Brady","year":"2011","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.apha.2023.10.006_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105809","article-title":"Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice","volume":"75","author":"Brandao","year":"2019","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-23274-9_7","article-title":"Muscarinic receptor pharmacology and circuitry for the modulation of cognition","volume":"208","author":"Bubser","year":"2012","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"6 Pt 1","key":"10.1016\/bs.apha.2023.10.006_bib23","first-page":"659","article-title":"Modafinil\u2014medical considerations for use in sustained operations","volume":"74","author":"Buguet","year":"2003","journal-title":"Aviation, Space, and Environmental Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainresbull.2010.08.010","article-title":"Effect of modafinil on learning performance and neocortical long-term potentiation in rats","volume":"83","author":"Burgos","year":"2010","journal-title":"Brain Research Bulletin"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jme.2009.030882","article-title":"Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology","volume":"35","author":"Cakic","year":"2009","journal-title":"Journal of Medical Ethics"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/ml1002025","article-title":"SARs at the monoamine transporters for a novel series of modafinil analogues","volume":"2","author":"Cao","year":"2011","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"23","key":"10.1016\/bs.apha.2023.10.006_bib27","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1021\/acs.jmedchem.6b01373","article-title":"Novel and high affinity 2-[(diphenylmethyl) sulfinyl] acetamide (modafinil) analogues as atypical dopamine transporter inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"issue":"9","key":"10.1016\/bs.apha.2023.10.006_bib28","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/bph.14626","article-title":"Modafinil protects hippocampal neurons by suppressing excessive autophagy and apoptosis in mice with sleep deprivation","volume":"176","author":"Cao","year":"2019","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.therap.2018.02.005","article-title":"Pharmaceutical cognitive doping in students: A chimeric way to get-a-head?","volume":"73","author":"Carton","year":"2018","journal-title":"Therapie"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib30","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.genhosppsych.2015.01.001","article-title":"Compulsive modafinil use in a patient with a history of alcohol use disorder","volume":"37","author":"Cengiz Mete","year":"2015","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/bs.apha.2023.10.006_bib31","unstructured":"Chadd. (2022). CHADD\u2019s National Resource Center; ADHD Medications Approved by the US FDA (infographic)."},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Dopamine, immunity, and disease","volume":"75","author":"Channer","year":"2023","journal-title":"Pharmacological Reviews"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"issue":"12","key":"10.1016\/bs.apha.2023.10.006_bib34","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nn756","article-title":"Synapsin dispersion and reclustering during synaptic activity","volume":"4","author":"Chi","year":"2001","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biopsycho.2006.01.005","article-title":"Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans","volume":"73","author":"Chudasama","year":"2006","journal-title":"Biological Psychology"},{"issue":"12","key":"10.1016\/bs.apha.2023.10.006_bib36","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.3390\/ijms23126602","article-title":"Modafinil administration to preadolescent rat impairs non-selective attention, frontal cortex D2 expression and mesolimbic GABA levels","volume":"23","author":"Cid-Jofr\u00e9","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2023.10.006_bib37","doi-asserted-by":"crossref","first-page":"81043","DOI":"10.52965\/001c.81043","article-title":"Bupropion mediated effects on depression, attention deficit hyperactivity disorder, and smoking cessation","volume":"11","author":"Clark","year":"2023","journal-title":"Health Psychology Research"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41398-022-02249-6","article-title":"Pharmacological targeting of cognitive impairment in depression: Recent developments and challenges in human clinical research","volume":"12","author":"Colwell","year":"2022","journal-title":"Translational Psychiatry"},{"issue":"9","key":"10.1016\/bs.apha.2023.10.006_bib39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/bs.apha.2023.10.006_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-801284-0.00001-4","article-title":"Neuroimmune mechanisms of alcohol and drug addiction","volume":"118","author":"Cui","year":"2014","journal-title":"International Review of Neurobiology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis","year":"2005","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7592","key":"10.1016\/bs.apha.2023.10.006_bib43","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/531S2a","article-title":"Smart drugs: A dose of intelligence","volume":"531","author":"Dance","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pharmthera.2008.10.004","article-title":"Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy","volume":"121","author":"Daws","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2023.10.006_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.drugalcdep.2009.08.013","article-title":"Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers","volume":"106","author":"De La Garza","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/10826084.2019.1691597","article-title":"Psychostimulant use for neuroenhancement (smart drugs) among college students in Brazil","volume":"55","author":"de Oliveira Cata Preta","year":"2020","journal-title":"Substance Use & Misuse"},{"issue":"16","key":"10.1016\/bs.apha.2023.10.006_bib47","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1097\/00001756-200111160-00032","article-title":"Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: A microdialysis study in rats","volume":"12","author":"de Saint Hilaire","year":"2001","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.jcp.0000104910.75206.b9","article-title":"A prospective trial of modafinil as an adjunctive treatment of major depression","volume":"24","author":"DeBattista","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2023.10.006_bib49","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/1535370221991830","article-title":"Dysregulation of brain dopamine systems in major depressive disorder","volume":"246","author":"Delva","year":"2021","journal-title":"Experimental Biology and Medicine (Maywood)"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-002-1080-8","article-title":"Study of the addictive potential of modafinil in naive and cocaine-experienced rats","volume":"161","author":"Deroche-Gamonet","year":"2002","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0004867414565480","article-title":"Could modafinil be a drug of dependence","volume":"49","author":"Dhillon","year":"2015","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2023.10.006_bib52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2007.03.044","article-title":"Modafinil evokes striatal [3H] dopamine release and alters the subjective properties of stimulants","volume":"568","author":"Dopheide","year":"2007","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib53","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.5665\/sleep.5854","article-title":"Impact of astroglial connexins on modafinil pharmacological properties","volume":"39","author":"Duch\u00eane","year":"2016","journal-title":"Sleep"},{"issue":"21","key":"10.1016\/bs.apha.2023.10.006_bib54","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2016.5260","article-title":"Treatment of fatigue in Parkinson disease","volume":"315","author":"Elbers","year":"2016","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240584","article-title":"Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis","volume":"15","author":"Elliott","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib56","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0306-4522(98)00015-3","article-title":"Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine","volume":"87","author":"Engber","year":"1998","journal-title":"Neuroscience"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2023.10.006_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(97)00962-2","article-title":"Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil","volume":"241","author":"Engber","year":"1998","journal-title":"Neuroscience Letters"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib58","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3357\/ASEM.3129.2012","article-title":"Modafinil as a replacement for dextroamphetamine for sustaining alertness in military helicopter pilots","volume":"83","author":"Estrada","year":"2012","journal-title":"Aviation, Space, and Environmental Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1460-9568.1994.tb00271.x","article-title":"Effects of apomorphine and L\u2010methionine sulphoximine on the release of excitatory amino acid neurotransmitters and glutamine in the striatum of the conscious rat","volume":"6","author":"Exposito","year":"1994","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/bs.apha.2023.10.006_bib60","unstructured":"FDA. (2015). Provigil consumer information. Retrieved from \u3008http:\/\/www.fda.gov\/cder\/consumerinfo\/druginfo\/provigil.htm\u3009."},{"issue":"13","key":"10.1016\/bs.apha.2023.10.006_bib61","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/00001756-199709080-00016","article-title":"The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus","volume":"8","author":"Ferraro","year":"1997","journal-title":"Neuroreport"},{"issue":"12","key":"10.1016\/bs.apha.2023.10.006_bib62","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(97)00353-3","article-title":"Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers","volume":"42","author":"Ferraro","year":"1997","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(98)00629-6","article-title":"The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: Evidence for a preferential inhibition of striato-pallidal GABA transmission","volume":"253","author":"Ferraro","year":"1998","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib64","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0893-133X(98)00085-2","article-title":"The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABA A receptor blockade","volume":"20","author":"Ferraro","year":"1999","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib65","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0028-3908(00)00019-8","article-title":"Amplification of cortical serotonin release: A further neurochemical action of the vigilance-promoting drug modafinil","volume":"39","author":"Ferraro","year":"2000","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jnr.10196","article-title":"Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: Possible relevance for wakefulness and depression","volume":"68","author":"Ferraro","year":"2002","journal-title":"Journal of Neuroscience Research"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(96)13212-2","article-title":"The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: Possible involvement of the serotonergic 5-HT3 receptor","volume":"220","author":"Ferraro","year":"1996","journal-title":"Neuroscience Letters"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2023.10.006_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(96)00182-3","article-title":"The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism","volume":"306","author":"Ferraro","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000514965","article-title":"The insomnia-addiction positive feedback loop: role of the orexin system","volume":"45","author":"Fragale","year":"2021","journal-title":"Frontiers of Neurology and Neuroscience"},{"key":"10.1016\/bs.apha.2023.10.006_bib70","first-page":"1","article-title":"The effect of modafinil on passive avoidance memory, brain level of BDNF and oxidative stress markers in sepsis survivor rats","author":"Garbossa","year":"2022","journal-title":"International Journal of Neuroscience"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib71","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/sleep\/30.11.1405","article-title":"Electrical coupling: Novel mechanism for sleep-wake control","volume":"30","author":"Garcia-Rill","year":"2007","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib72","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/npp.2010.233","article-title":"Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals","volume":"36","author":"Ghahremani","year":"2011","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"6566","key":"10.1016\/bs.apha.2023.10.006_bib73","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib74","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02247379","article-title":"Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil","volume":"126","author":"Gold","year":"1996","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1353\/ken.0.0309","article-title":"Cognitive enhancement, cheating, and accomplishment","volume":"20","author":"Goodman","year":"2010","journal-title":"Kennedy Institute of Ethics Journal"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib76","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/npp.2011.260","article-title":"Modulation of fronto-cortical activity by modafinil: A functional imaging and fos study in the rat","volume":"37","author":"Gozzi","year":"2012","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib77","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(02)00026-X","article-title":"Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity","volume":"111","author":"Gu","year":"2002","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib78","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/biom13060922","article-title":"Microglia NLRP3 inflammasome and neuroimmune signaling in substance use disorders","volume":"13","author":"Guo","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib79","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiological Reviews"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jneumeth.2011.01.023","article-title":"Ex vivo identification of protein\u2013protein interactions involving the dopamine transporter","volume":"196","author":"Hadlock","year":"2011","journal-title":"Journal of Neuroscience Methods"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib81","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10787-017-0387-3","article-title":"Modafinil attenuates inflammation via inhibiting Akt\/NF-kappaB pathway in apoE-deficient mouse model of atherosclerosis","volume":"26","author":"Han","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2023.10.006_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103154","article-title":"High resolution mapping of modafinil induced changes in glutamate level in rat brain","volume":"9","author":"Haris","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib83","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"19","key":"10.1016\/bs.apha.2023.10.006_bib84","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1074\/jbc.RA118.001753","article-title":"Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes","volume":"293","author":"Herborg","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.10.006_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.656475","article-title":"Psychostimulant use disorder, an unmet therapeutic goal: Can modafinil narrow the gap?","volume":"15","author":"Hersey","year":"2021","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apha.2023.10.006_bib86","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.3c00354","article-title":"An FSCV study on the effects of targeted typical and atypical DAT inhibition on dopamine dynamics in the nucleus accumbens shell of male and female mice","author":"Hersey","year":"2023","journal-title":"ACS Chemical Neuroscience"},{"issue":"30","key":"10.1016\/bs.apha.2023.10.006_bib87","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1523\/JNEUROSCI.2618-20.2021","article-title":"Inflammation-induced histamine impairs the capacity of escitalopram to increase hippocampal extracellular serotonin","volume":"41","author":"Hersey","year":"2021","journal-title":"Journal of Neuroscience"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib88","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1037\/a0021791","article-title":"The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence","volume":"18","author":"Hester","year":"2010","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2023.10.006_bib89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2011.07.010","article-title":"Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone","volume":"120","author":"Holtz","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib90","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2010.08.005","article-title":"Modanifil activates the histaminergic system through the orexinergic neurons","volume":"483","author":"Ishizuka","year":"2010","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(03)00006-5","article-title":"Modafinil increases histamine release in the anterior hypothalamus of rats","volume":"339","author":"Ishizuka","year":"2003","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","article-title":"An evaluation of the abuse potential of modafinil using methylphenidate as a reference","volume":"14","author":"Jasinski","year":"2000","journal-title":"Journal of psychopharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib93","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1521-0391.2010.00052.x","article-title":"Modafinil administration improves working memory in methamphetamine\u2010dependent individuals who demonstrate baseline impairment","volume":"19","author":"Kalechstein","year":"2010","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/bs.apha.2023.10.006_bib94","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.neuropharm.2012.06.064","article-title":"Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users","volume":"64","author":"Kalechstein","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib95","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib96","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/sleep\/32.2.181","article-title":"CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome","volume":"32","author":"Kanbayashi","year":"2009","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib97","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10571-022-01223-6","article-title":"Neuroinflammatory response in reward-associated psychostimulants and opioids: A review","volume":"43","author":"Karimi-Haghighi","year":"2023","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib98","article-title":"Dependence on supratherapeutic doses of modafinil: a case report","volume":"14","author":"Kate","year":"2012","journal-title":"The Primary Care Companion for CNS Disorders"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41398-023-02493-4","article-title":"Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release","volume":"13","author":"Keighron","year":"2023","journal-title":"Translational Psychiatry"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib100","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/ejn.14256","article-title":"Distinct effects of (R)\u2010modafinil and its (R)\u2010and (S)\u2010fluoro\u2010analogs on mesolimbic extracellular dopamine assessed by voltammetry and microdialysis in rats","volume":"50","author":"Keighron","year":"2019","journal-title":"European Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib101","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/acschemneuro.8b00340","article-title":"Effects of (R)-modafinil and modafinil analogues on dopamine dynamics assessed by voltammetry and microdialysis in the mouse nucleus accumbens shell","volume":"10","author":"Keighron","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib102","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/32.2.205","article-title":"Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil","volume":"32","author":"Killgore","year":"2009","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib103","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2869.2008.00654.x","article-title":"Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44h of continuous wakefulness","volume":"17","author":"Killgore","year":"2008","journal-title":"Journal of Sleep Research"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib104","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2014.03.031","article-title":"Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine","volume":"76","author":"Kohut","year":"2014","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuropharm.2006.09.005","article-title":"Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors","volume":"52","author":"Korotkova","year":"2007","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0976-500X.149149","article-title":"A rare case modafinil dependence","volume":"6","author":"Krishnan","year":"2015","journal-title":"Journal of Pharmacology & Pharmacotherapeutics"},{"issue":"7","key":"10.1016\/bs.apha.2023.10.006_bib107","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","article-title":"The dopamine hypothesis of the reinforcing properties of cocaine","volume":"14","author":"Kuhar","year":"1991","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/bs.apha.2023.10.006_bib108","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuro.2020.02.014","article-title":"Memory improvement by modafinil at cost of metabolic hazards? A study to decipher the benefits and risks of modafinil in rats","volume":"78","author":"Kumar","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/bs.apha.2023.10.006_bib109","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2165\/00003495-200868130-00003","article-title":"Approved and investigational uses of modafinil: An evidence-based review","volume":"68","author":"Kumar","year":"2008","journal-title":"Drugs"},{"issue":"13","key":"10.1016\/bs.apha.2023.10.006_bib110","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1017\/S0033291717000885","article-title":"Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: The effects of test battery in a randomised controlled trial","volume":"47","author":"Lees","year":"2017","journal-title":"Psychological Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib111","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0896-6273(02)01132-7","article-title":"Hypocretin\/orexin excites hypocretin neurons via a local glutamate neuron\u2014A potential mechanism for orchestrating the hypothalamic arousal system","volume":"36","author":"Li","year":"2002","journal-title":"Neuron"},{"issue":"24","key":"10.1016\/bs.apha.2023.10.006_bib112","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.93.24.14128","article-title":"Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat","volume":"93","author":"Lin","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib113","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1345\/aph.1H024","article-title":"Use of modafinil for the treatment of attention deficit\/hyperactivity disorder","volume":"40","author":"Lindsay","year":"2006","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/bs.apha.2023.10.006_bib114","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuropharm.2013.04.019","article-title":"The psychostimulant modafinil enhances gap junctional communication in cortical astrocytes","volume":"75","author":"Liu","year":"2013","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib116","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","article-title":"R-modafinil (armodafinil): A unique dopamine uptake inhibitor and potential medication for psychostimulant abuse","volume":"72","author":"Loland","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib117","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"9","key":"10.1016\/bs.apha.2023.10.006_bib118","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1017\/S1461145711001805","article-title":"Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers","volume":"15","author":"Mahoney","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077967","article-title":"To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students","volume":"8","author":"Maier","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00952990600920425","article-title":"Modafinil and cocaine interactions","volume":"32","author":"Malcolm","year":"2006","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/bs.apha.2023.10.006_bib121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00023210-199809040-00006","article-title":"Modafinil: A review of its pharmacology and clinical efficacy in the management of narcolepsy","volume":"9","author":"McClellan","year":"1998","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib122","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/00952990802342907","article-title":"Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: A pilot study","volume":"35","author":"McElhiney","year":"2009","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"8","key":"10.1016\/bs.apha.2023.10.006_bib123","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0149-7634(99)00067-6","article-title":"5-HT system and cognition","volume":"23","author":"Meneses","year":"1999","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib124","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-013-3232-4","article-title":"The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders","volume":"229","author":"Mereu","year":"2013","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/ejn.13376","article-title":"The unique psychostimulant profile of (\u00b1)\u2010modafinil: Investigation of behavioral and neurochemical effects in mice","volume":"45","author":"Mereu","year":"2017","journal-title":"European Journal of Neuroscience"},{"issue":"9","key":"10.1016\/bs.apha.2023.10.006_bib126","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41386-020-0680-5","article-title":"Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: Possible involvement of gap junctions","volume":"45","author":"Mereu","year":"2020","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib127","first-page":"436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep-New York"},{"key":"10.1016\/bs.apha.2023.10.006_bib128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000514959","article-title":"Sleep problems in narcolepsy and the role of hypocretin\/orexin deficiency","volume":"45","author":"Mignot","year":"2021","journal-title":"Frontiers of Neurology and Neuroscience"},{"issue":"7","key":"10.1016\/bs.apha.2023.10.006_bib129","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: A review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00213-010-2111-5","article-title":"Modafinil modulation of the default mode network","volume":"215","author":"Minzenberg","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41398-018-0104-z","article-title":"Altered brainstem responses to modafinil in schizophrenia: Implications for adjunctive treatment of cognition","volume":"8","author":"Minzenberg","year":"2018","journal-title":"Translational Psychiatry"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib132","doi-asserted-by":"crossref","first-page":"257","DOI":"10.20344\/amp.14220","article-title":"Use of cognitive enhancers by portuguese medical students: Do academic challenges matter","volume":"35","author":"Miranda","year":"2022","journal-title":"Acta Medica Portuguesa"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib133","first-page":"165","article-title":"Effects of modafinil on sleep pattern during methamphetamine withdrawal: A double-blind randomized controlled trial","volume":"11","author":"Moosavi","year":"2019","journal-title":"Addiction & Health"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib134","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/schbul\/sbm090","article-title":"A review of the effects of modafinil on cognition in schizophrenia","volume":"33","author":"Morein-Zamir","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/bs.apha.2023.10.006_bib135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.drugalcdep.2015.11.024","article-title":"Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10","volume":"158","author":"Moreira","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.apha.2023.10.006_bib136","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2015.12.004","article-title":"Modafinil and sleep architecture in an inpatient\u2013outpatient treatment study of cocaine dependence","volume":"160","author":"Morgan","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib137","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1176\/appi.ajp.2009.09050613","article-title":"Normalizing effects of modafinil on sleep in chronic cocaine users","volume":"167","author":"Morgan","year":"2010","journal-title":"American Journal of Psychiatry"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2023.10.006_bib138","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00213-004-1926-3","article-title":"Effects of modafinil on working memory processes in humans","volume":"177","author":"M\u00fcller","year":"2004","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib139","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acschemneuro.7b00374","article-title":"An overview of the clinical uses, pharmacology, and safety of modafinil","volume":"9","author":"Murillo-Rodr\u00edguez","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbr.2006.10.016","article-title":"Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats","volume":"176","author":"Murillo-Rodr\u00edguez","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.apha.2023.10.006_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.650785","article-title":"Neuroimmune mechanisms as novel treatment targets for substance use disorders and associated comorbidities","volume":"15","author":"Namba","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"8","key":"10.1016\/bs.apha.2023.10.006_bib142","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41386-019-0366-z","article-title":"Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders","volume":"44","author":"Newman","year":"2019","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib143","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1037\/a0021042","article-title":"Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys","volume":"18","author":"Newman","year":"2010","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"8","key":"10.1016\/bs.apha.2023.10.006_bib144","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/syn.20892","article-title":"Modafinil\u2010induced conditioned place preference via dopaminergic system in mice","volume":"65","author":"Nguyen","year":"2011","journal-title":"Synapse (New York, N. Y.)"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(01)02270-4","article-title":"Decreased brain histamine content in hypocretin\/orexin receptor-2 mutated narcoleptic dogs","volume":"313","author":"Nishino","year":"2001","journal-title":"Neuroscience Letters"},{"issue":"9197","key":"10.1016\/bs.apha.2023.10.006_bib146","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib147","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/sleep\/32.2.175","article-title":"Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls","volume":"32","author":"Nishino","year":"2009","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib148","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bdi.12859","article-title":"Efficacy and tolerability of adjunctive modafinil\/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials","volume":"22","author":"Nunez","year":"2020","journal-title":"Bipolar Disorders"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib149","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/jm401754x","article-title":"Elucidation of structural elements for selectivity across monoamine transporters: Novel 2-[(diphenylmethyl) sulfinyl] acetamide (modafinil) analogues","volume":"57","author":"Okunola-Bakare","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"issue":"12","key":"10.1016\/bs.apha.2023.10.006_bib150","first-page":"CD008661","article-title":"Modafinil for people with schizophrenia or related disorders","volume":"12","author":"Ortiz-Orendain","year":"2019","journal-title":"Cochrane Database of Systematic Reviews ((Online))"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib151","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1460-9568.2008.06496.x","article-title":"Activity\u2010dependent regulation of the dopamine transporter is mediated by Ca2+\/calmodulin\u2010dependent protein kinase signaling","volume":"28","author":"Padmanabhan","year":"2008","journal-title":"European Journal of Neuroscience"},{"issue":"8","key":"10.1016\/bs.apha.2023.10.006_bib152","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.bcp.2007.01.002","article-title":"The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders","volume":"73","author":"Parmentier","year":"2007","journal-title":"Biochemical Pharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028416","article-title":"Smart drugs \u201cas common as coffee\u201d: media hype about neuroenhancement","volume":"6","author":"Partridge","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2023.10.006_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nlm.2017.08.007","article-title":"Histamine regulates memory consolidation","volume":"145","author":"Passani","year":"2017","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/bs.apha.2023.10.006_bib155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3389\/fphar.2018.01189","article-title":"Smarter Than Thou, Holier Than Thou: The dynamic interplay between cognitive and moral enhancement","volume":"9","author":"Pavarini","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib156","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2007.11.027","article-title":"Memory formation, amnesia, improved memory and reversed amnesia: 5-HT role","volume":"195","author":"Perez-Garcia","year":"2008","journal-title":"Behavioural Brain Research"},{"issue":"9","key":"10.1016\/bs.apha.2023.10.006_bib157","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib158","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: Cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8110197","article-title":"Use and propensity to use substances as cognitive enhancers in italian medical students","volume":"8","author":"Pighi","year":"2018","journal-title":"Brain Sciences"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib160","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/j.1460-9568.1995.tb00640.x","article-title":"Dopamine\u2010glutamate\u2010GABA interactions and ageing: Studies in the striatum of the conscious rat","volume":"7","author":"Porras","year":"1995","journal-title":"European Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib161","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00213-013-3186-6","article-title":"Early markers of cognitive enhancement: Developing an implicit measure of cognitive performance","volume":"230","author":"Pringle","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"34","key":"10.1016\/bs.apha.2023.10.006_bib162","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1523\/JNEUROSCI.1819-08.2008","article-title":"Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil","volume":"28","author":"Qu","year":"2008","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib163","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1037\/a0031832","article-title":"Modafinil alone and in combination with low dose amphetamine does not establish conditioned place preference in male sprague-dawley rats","volume":"21","author":"Quisenberry","year":"2013","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046599","article-title":"Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum","volume":"7","author":"Raineri","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(77)90202-3","article-title":"Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine","volume":"41","author":"Raiteri","year":"1977","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241968","article-title":"Professionals\u2019 attitudes towards the use of cognitive enhancers in academic settings","volume":"15","author":"Ram","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib167","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hup.456","article-title":"Modafinil affects mood, but not cognitive function, in healthy young volunteers","volume":"18","author":"Randall","year":"2003","journal-title":"Human Psychopharmacology"},{"issue":"12","key":"10.1016\/bs.apha.2023.10.006_bib168","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1172\/JCI32829","article-title":"Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin\/orexin neurons","volume":"117","author":"Rao","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib169","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/npp.2010.83","article-title":"Modulatory effects of modafinil on neural circuits regulating emotion and cognition","volume":"35","author":"Rasetti","year":"2010","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00213-010-1828-5","article-title":"Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse","volume":"210","author":"Reichel","year":"2010","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2023.10.006_bib171","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1017\/S1461145711000988","article-title":"Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats","volume":"15","author":"Reichel","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"4819","key":"10.1016\/bs.apha.2023.10.006_bib173","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.apha.2023.10.006_bib174","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-200342020-00002","article-title":"Clinical pharmacokinetic profile of modafinil","volume":"42","author":"Robertson","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib175","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0090-9556(24)15146-X","article-title":"In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil","volume":"28","author":"Robertson","year":"2000","journal-title":"Drug Metabolism and Disposition"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib176","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002826-200401000-00011","article-title":"Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia","volume":"27","author":"Rosenthal","year":"2004","journal-title":"Clinical Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib177","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0269881113513850","article-title":"Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats","volume":"28","author":"Rowley","year":"2014","journal-title":"Journal of psychopharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib178","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0887-8994(03)00148-6","article-title":"Modafinil in children with attention-deficit hyperactivity disorder","volume":"29","author":"Rugino","year":"2003","journal-title":"Pediatric Neurology"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib179","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0376-8716(02)00082-0","article-title":"Discriminative-stimulus effects of modafinil in cocaine-trained humans","volume":"67","author":"Rush","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00008877-200203000-00002","article-title":"Acute behavioral and physiological effects of modafinil in drug abusers","volume":"13","author":"Rush","year":"2002","journal-title":"Behavioural Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib181","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4088\/JCP.07r03982","article-title":"Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: A critical review","volume":"70","author":"Saavedra-Velez","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib182","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/JCP.0000000000001124","article-title":"Prodopaminergic drugs for treating the negative symptoms of schizophrenia: Systematic review and meta-analysis of randomized controlled trials","volume":"39","author":"Sabe","year":"2019","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"22","key":"10.1016\/bs.apha.2023.10.006_bib183","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"Journal of Neuroscience"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib184","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40265-022-01701-7","article-title":"Benefits and harms of \u2018smart drugs\u2019 (nootropics) in healthy individuals","volume":"82","author":"Schifano","year":"2022","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025790","article-title":"The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors","volume":"6","author":"Schmitt","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/bs.apha.2023.10.006_bib186","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3233\/JPD-212749","article-title":"Management of sleep disturbances in Parkinson\u2019 disease","volume":"12","author":"Schutz","year":"2022","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"10.1016\/bs.apha.2023.10.006_bib187","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuropharm.2012.07.011","article-title":"Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain","volume":"64","author":"Scoriels","year":"2013","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib188","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1096\/fasebj.4.10.2197154","article-title":"Dopamine receptors and transporters in Parkinson\u2019s disease and schizophrenia","volume":"4","author":"Seeman","year":"1990","journal-title":"The FASEB Journal"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262704","article-title":"Assessing prevalence, knowledge and use of cognitive enhancers among university students in the United Arab Emirates: A quantitative study","volume":"17","author":"Sharif","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib190","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/brainsci11030355","article-title":"The use and impact of cognitive enhancers among university students: A systematic review","volume":"11","author":"Sharif","year":"2021","journal-title":"Brain Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib191","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","article-title":"A double\u2010blind, placebo\u2010controlled trial of modafinil (200 mg\/day) for methamphetamine dependence","volume":"104","author":"Shearer","year":"2009","journal-title":"Addiction (Abingdon, England)"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib192","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2012.07.039","article-title":"Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction","volume":"235","author":"Shuman","year":"2012","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.apha.2023.10.006_bib193","first-page":"1","article-title":"A critical review of hot executive functioning in youth attention-deficit\/hyperactivity disorder: Methodological limitations, conceptual considerations, and future directions","author":"Smith","year":"2023","journal-title":"Development and Psychopathology"},{"key":"10.1016\/bs.apha.2023.10.006_bib194","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuropharm.2012.06.021","article-title":"Cognitive enhancement as a treatment for drug addictions","volume":"64","author":"Sofuoglu","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/15504263.2016.1146383","article-title":"Cognitive function as a transdiagnostic treatment target in stimulant use disorders","volume":"12","author":"Sofuoglu","year":"2016","journal-title":"Journal of Dual Diagnosis"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib196","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/08897077.2019.1700584","article-title":"Pharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects","volume":"41","author":"Sousa","year":"2020","journal-title":"Substance abuse"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib197","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/syn.10127","article-title":"Role of brain \u03b11B\u2010adrenoceptors in modafinil\u2010induced behavioral activity","volume":"46","author":"Stone","year":"2002","journal-title":"Synapse (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib198","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-005-0044-1","article-title":"Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration","volume":"182","author":"Stoops","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib199","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000514963","article-title":"Hypocretin\/orexin receptor pharmacology and sleep phases","volume":"45","author":"Sun","year":"2021","journal-title":"Frontiers of Neurology and Neuroscience"},{"issue":"6","key":"10.1016\/bs.apha.2023.10.006_bib200","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/acps.12712","article-title":"Dopaminergic agents in the treatment of bipolar depression: A systematic review and meta-analysis","volume":"135","author":"Szmulewicz","year":"2017","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib201","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1038\/npp.2010.94","article-title":"Modafinil blocks reinstatement of extinguished opiate-seeking in rats: mediation by a glutamate mechanism","volume":"35","author":"Tahsili-Fahadan","year":"2010","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coph.2020.07.007","article-title":"Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder","volume":"56","author":"Tanda","year":"2021","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)57007-4","article-title":"Discovery of drugs to treat cocaine dependence: Behavioral and neurochemical effects of atypical dopamine transport inhibitors","volume":"57","author":"Tanda","year":"2009","journal-title":"Advances in Pharmacology"},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib204","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1460-9568.1997.tb01375.x","article-title":"Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine","volume":"9","author":"Tanda","year":"1997","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.apha.2023.10.006_bib205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00176625","article-title":"Inhibitory effects of the psychoactive drug modafinil on \u03b3-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig: Possible involvement of 5-hydroxytryptamine mechanisms","volume":"345","author":"Tanganelli","year":"1992","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2000.10.311","article-title":"Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults","volume":"10","author":"Taylor","year":"2000","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib207","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","article-title":"Histamine in the regulation of wakefulness","volume":"15","author":"Thakkar","year":"2011","journal-title":"Sleep Medicine Reviews"},{"key":"10.1016\/bs.apha.2023.10.006_bib208","unstructured":"The Orexin System. Basic Science and Role in Sleep Pathology. (2021). (Vol. 45). Basel: S. Karger AG."},{"issue":"S6","key":"10.1016\/bs.apha.2023.10.006_bib209","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10696","article-title":"Gaba, \u03b3\u2010hydroxybutyric acid, and neurological disease","volume":"54","author":"Ting Wong","year":"2003","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2023.10.006_bib210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0169-328X(94)90082-5","article-title":"Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain","volume":"26","author":"Touret","year":"1994","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1016\/bs.apha.2023.10.006_bib211","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnbeh.2013.00028","article-title":"Role of orexin in modulating arousal, feeding, and motivation","volume":"7","author":"Tsujino","year":"2013","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib212","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1586\/14737175.6.4.455","article-title":"A review of the use of modafinil for attention-deficit hyperactivity disorder","volume":"6","author":"Turner","year":"2006","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"7","key":"10.1016\/bs.apha.2023.10.006_bib213","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/sj.npp.1300457","article-title":"Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia","volume":"29","author":"Turner","year":"2004","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib214","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00213-002-1250-8","article-title":"Cognitive enhancing effects of modafinil in healthy volunteers","volume":"165","author":"Turner","year":"2003","journal-title":"Psychopharmacology"},{"issue":"30","key":"10.1016\/bs.apha.2023.10.006_bib215","doi-asserted-by":"crossref","first-page":"12554","DOI":"10.1073\/pnas.0705087104","article-title":"Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling","volume":"104","author":"Urbano","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib216","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41386-019-0465-x","article-title":"Drugs, sleep, and the addicted brain","volume":"45","author":"Valentino","year":"2020","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2023.10.006_bib217","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-981-19-7376-5_15","article-title":"A potential role for neuroinflammation in ADHD","volume":"1411","author":"Vazquez-Gonzalez","year":"2023","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"12","key":"10.1016\/bs.apha.2023.10.006_bib218","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1523\/JNEUROSCI.4901-04.2006","article-title":"Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool","volume":"26","author":"Venton","year":"2006","journal-title":"Journal of Neuroscience"},{"issue":"11","key":"10.1016\/bs.apha.2023.10.006_bib219","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1016\/bs.apha.2023.10.006_bib220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jpsychires.2016.09.034","article-title":"Modafinil for the treatment of attention-deficit\/hyperactivity disorder: A meta-analysis","volume":"84","author":"Wang","year":"2017","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1016\/bs.apha.2023.10.006_bib221","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/npp.2015.24","article-title":"R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats","volume":"40","author":"Wang","year":"2015","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib222","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0924933800002923","article-title":"Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: A comparison with amphetamine, caffeine and placebo","volume":"8","author":"Warot","year":"1993","journal-title":"European Psychiatry"},{"issue":"20","key":"10.1016\/bs.apha.2023.10.006_bib223","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2174\/138161206777698819","article-title":"Effects of modafinil on cognitive performance and alertness during sleep deprivation","volume":"12","author":"Wesensten","year":"2006","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/bs.apha.2023.10.006_bib224","unstructured":"Whitmore, J., Hickey, P., Doan, B., Harrison, R., Kisner, J., Beltran, T., ... Marks, F., & Air Force Research Lab Brooks AFB TX Human Effectiveness DIR\/Biodynamics and Protection Div (2006). A double-blind placebo-controlled investigation of the efficacy of modafinil for maintaining alertness and performance in sustained military ground operations. Technical report January 2003\u2013November 2005. Available at http:\/\/oai.dtic.mil\/oai\/oai? verb=getRecord&metadataPrefix=html&identifier=ADA454558."},{"issue":"10","key":"10.1016\/bs.apha.2023.10.006_bib225","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1586\/ern.11.137","article-title":"An update on the pharmacotherapy of attention-deficit\/hyperactivity disorder in adults","volume":"11","author":"Wilens","year":"2011","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"9","key":"10.1016\/bs.apha.2023.10.006_bib226","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7150\/ijbs.6426","article-title":"Glutamate, glutamate receptors, and downstream signaling pathways","volume":"9","author":"Willard","year":"2013","journal-title":"International Journal of Biological Sciences"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib227","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2004.10.005","article-title":"Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates","volume":"130","author":"Willie","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apha.2023.10.006_bib228","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fneur.2013.00139","article-title":"Modafinil as a catecholaminergic agent: Empirical evidence and unanswered questions","volume":"4","author":"Wisor","year":"2013","journal-title":"Frontiers in Neurology"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib229","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib230","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/j.1552-4604.1998.tb04425.x","article-title":"Single\u2010dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers","volume":"38","author":"Wong","year":"1998","journal-title":"The Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib231","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/009127009903900312","article-title":"Open\u2010label, single\u2010dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects","volume":"39","author":"Wong","year":"1999","journal-title":"The Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2023.10.006_bib232","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/00912709922007534","article-title":"A double\u2010blind, placebo\u2010controlled, ascending\u2010dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers","volume":"39","author":"Wong","year":"1999","journal-title":"The Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib233","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1369-1600.2011.00341.x","article-title":"Addictive potential of modafinil and cross\u2010sensitization with cocaine: A pre\u2010clinical study","volume":"16","author":"Wuo\u2010Silva","year":"2011","journal-title":"Addiction Biology"},{"issue":"5","key":"10.1016\/bs.apha.2023.10.006_bib234","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/aps.2017.172","article-title":"GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia","volume":"39","author":"Xu","year":"2018","journal-title":"Acta Pharmacologica Sinica"},{"issue":"4","key":"10.1016\/bs.apha.2023.10.006_bib235","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1006\/bbrc.2001.6318","article-title":"Orexins activate histaminergic neurons via the orexin 2 receptor","volume":"290","author":"Yamanaka","year":"2002","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2023.10.006_bib236","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fnins.2019.00195","article-title":"Expression of dopamine receptors in the lateral hypothalamic nucleus and their potential regulation of gastric motility in rats with lesions of bilateral substantia nigra","volume":"13","author":"Yang","year":"2019","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apha.2023.10.006_bib237","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbi.2020.04.038","article-title":"Modulating the immune response with the wake-promoting drug modafinil: A potential therapeutic approach for inflammatory disorders","volume":"88","author":"Zager","year":"2020","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.apha.2023.10.006_bib238","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.pnpbp.2017.05.003","article-title":"The wake-promoting drug Modafinil prevents motor impairment in sickness behavior induced by LPS in mice: Role for dopaminergic D1 receptor","volume":"81","author":"Zager","year":"2018","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/bs.apha.2023.10.006_bib239","first-page":"67","article-title":"The effect of long-acting methylphenidate and modafinil on attention and impulsivity of children with ADHD using a continuous performance test: A comparative study","volume":"16","author":"Zahed","year":"2022","journal-title":"Iranian Journal of Child Neurology"},{"issue":"7","key":"10.1016\/bs.apha.2023.10.006_bib240","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/FBP.0b013e328331b9db","article-title":"Modafinil and gamma-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep","volume":"20","author":"Zeitzer","year":"2009","journal-title":"Behavioural Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.10.006_bib241","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.108.146142","article-title":"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil","volume":"329","author":"Zolkowska","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Advances in Pharmacology","Pharmacological Advances in Central Nervous System Stimulants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105435892300056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105435892300056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:27:16Z","timestamp":1762360036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105435892300056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443219337"],"references-count":241,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2023.10.006","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}